Julius A. Vida
Nessuna posizione attualmente
Storia della carriera di Julius A. Vida
Precedenti posizioni note di Julius A. Vida
Società | Posizione | Inizio | Fine |
---|---|---|---|
Vida International Pharmaceutical Consultants | Fondatore | 11/05/2011 | 10/06/2018 |
Presidente | 01/01/1993 | 10/06/2018 | |
OsteoScreen, Inc. | Direttore/Membro del Consiglio | - | 10/06/2018 |
Almac Sciences (Scotland) Ltd.
Almac Sciences (Scotland) Ltd. Chemicals: SpecialtyProcess Industries Part of Chemical Synthesis Services Business, Almac Sciences (Scotland) Ltd. is a British company that produces custom peptides and proteins. The company is based in Penicuik, UK. | Direttore/Membro del Consiglio | - | 10/06/2018 |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Direttore/Membro del Consiglio | 01/02/1994 | 27/08/2009 |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Direttore/Membro del Consiglio | - | 28/11/2007 |
Orphan Medical, Inc.
Orphan Medical, Inc. Pharmaceuticals: MajorHealth Technology Orphan Medical, Inc. develops and markets pharmaceutical and health care products. The company was founded in 1993 and is located in Minnetonka, MN. | Direttore/Membro del Consiglio | - | 27/06/2005 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/1993 | 01/01/1993 |
Almac Group Ltd.
Almac Group Ltd. Pharmaceuticals: MajorHealth Technology Almac Group Ltd. manufactures and distributes pharmaceutical products. The firm’s services include diagnostics, API services and chemical development, pharmaceutical development, analytical and solid state services, clinical services, clinical technologies and commercial services. The company was founded by Allen McClay in 2002 and is headquartered in Craigavon, the United Kingdom. | Direttore/Membro del Consiglio | - | - |
FIBROGEN, INC. | Direttore/Membro del Consiglio | - | - |
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Formazione di Julius A. Vida
The Trustees of Columbia University in The City of New York | Masters Business Admin |
Carnegie Mellon University | Doctorate Degree |
Eotvos Lorand University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 10 |
Regno Unito | 4 |
Ungheria | 2 |
Posizioni
Director/Board Member | 8 |
Masters Business Admin | 1 |
Founder | 1 |
Settori
Health Technology | 7 |
Consumer Services | 4 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
FIBROGEN, INC. | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Aziende private | 7 |
---|---|
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Commercial Services |
Orphan Medical, Inc.
Orphan Medical, Inc. Pharmaceuticals: MajorHealth Technology Orphan Medical, Inc. develops and markets pharmaceutical and health care products. The company was founded in 1993 and is located in Minnetonka, MN. | Health Technology |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Health Technology |
Almac Group Ltd.
Almac Group Ltd. Pharmaceuticals: MajorHealth Technology Almac Group Ltd. manufactures and distributes pharmaceutical products. The firm’s services include diagnostics, API services and chemical development, pharmaceutical development, analytical and solid state services, clinical services, clinical technologies and commercial services. The company was founded by Allen McClay in 2002 and is headquartered in Craigavon, the United Kingdom. | Health Technology |
Vida International Pharmaceutical Consultants | |
OsteoScreen, Inc. | |
Almac Sciences (Scotland) Ltd.
Almac Sciences (Scotland) Ltd. Chemicals: SpecialtyProcess Industries Part of Chemical Synthesis Services Business, Almac Sciences (Scotland) Ltd. is a British company that produces custom peptides and proteins. The company is based in Penicuik, UK. | Process Industries |
- Borsa valori
- Insiders
- Julius A. Vida
- Esperienza